Paper3909643
Chemotherapy for herpes simplex virus infections.
Erlich KS and 1 other. West J Med, 1985. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Chemotherapy for herpes simplex virus infections. Papers, record 3909643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3909643
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Herpes Simplex | Major topic |
| Acyclovir | |
| Administration, Oral | |
| Administration, Topical | |
| Child | |
| Encephalitis | |
| Female | |
| Herpes Genitalis | |
| Herpes Labialis | |
| Humans | |
| Idoxuridine | |
| Infant, Newborn | |
| Male | |
| Pregnancy | |
| Stomatitis, Herpetic | |
| Vidarabine |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5,333,786 | History of herpes genitalis. | Br J Vener Dis | 1966 | https://conductscience.org/library/papers/5333786 | PubMed |
| 2 | 6,148,470 | Acyclovir versus vidarabine in herpes simplex encephalitis. Randomised multicentre study in consecutive Swedish patients. | Lancet | 1984 | https://conductscience.org/library/papers/6148470 | PubMed |
| 3 | 4,327,432 | Genital herpes in two social groups. | Am J Obstet Gynecol | 1971 | https://conductscience.org/library/papers/4327432 | PubMed |
| 4 | 4,347,057 | Recovery of herpes-simplex virus from human trigeminal ganglions. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4347057 | PubMed |
| 5 | 4,348,966 | Pathogenesis of herpetic neuritis and ganglionitis in mice: evidence for intra-axonal transport of infection. | Infect Immun | 1973 | https://conductscience.org/library/papers/4348966 | PubMed |
| 6 | 4,353,782 | Infection with herpes-simplex viruses 1 and 2. II. | N Engl J Med | 1973 | https://conductscience.org/library/papers/4353782 | PubMed |
| 7 | 164,768 | Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. | Am J Epidemiol | 1975 | https://conductscience.org/library/papers/164768 | PubMed |
| 8 | 49,654 | Immunological basis for latency, recurrences and putative oncogenicity of herpes simplex virus. | Lancet | 1975 | https://conductscience.org/library/papers/49654 | PubMed |
| 9 | 55,654 | An alternative theory of herpes-simplex recurrence and a possible role for prostaglandins. | Lancet | 1976 | https://conductscience.org/library/papers/55654 | PubMed |
| 10 | 191,771 | Herpes simplex virus type 2 meningitis. | Obstet Gynecol | 1977 | https://conductscience.org/library/papers/191771 | PubMed |
| 11 | 194,157 | The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. | N Engl J Med | 1977 | https://conductscience.org/library/papers/194157 | PubMed |
| 12 | 195,208 | Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. | N Engl J Med | 1977 | https://conductscience.org/library/papers/195208 | PubMed |
| 13 | 426,465 | An explanation for the localization of herpes simplex encephalitis? | Ann Neurol | 1979 | https://conductscience.org/library/papers/426465 | PubMed |
| 14 | 6,247,969 | Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo. | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6247969 | PubMed |
| 15 | 7,001,331 | Vidarabine therapy of neonatal herpes simplex virus infection. | Pediatrics | 1980 | https://conductscience.org/library/papers/7001331 | PubMed |
| 16 | 6,255,332 | Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6255332 | PubMed |
| 17 | 6,113,352 | Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. | Lancet | 1981 | https://conductscience.org/library/papers/6113352 | PubMed |
| 18 | 6,264,292 | Acyclovir prophylaxis of herpes-simplex-virus infections. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6264292 | PubMed |
| 19 | 6,264,300 | Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response. | N Engl J Med | 1981 | https://conductscience.org/library/papers/6264300 | PubMed |
| 20 | 6,275,267 | Resistance to antiviral drugs of herpes simplex virus isolated from a patient treated with acyclovir. | N Engl J Med | 1982 | https://conductscience.org/library/papers/6275267 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26,255,831 | Therapeutic Strategy for the Prevention of Pseudorabies Virus Infection in C57BL/6 Mice by 3D8 scFv with Intrinsic Nuclease Activity. | Mol Cells | 2015 | https://conductscience.org/library/papers/26255831 | PubMed |
| 24,968,358 | A nucleic-acid hydrolyzing single chain antibody confers resistance to DNA virus infection in hela cells and C57BL/6 mice. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/24968358 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3909643
GET https://conductscience.org/api/papers/v1/3909643/references?page=2